Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix to Develop Alzheimer s Diagnostic with Case Western Researchers

NEW YORK, Feb. 23 (GenomeWeb News) - Acacia Research group CombiMatrix will collaborate with researchers at Case Western Reserve University to develop a diagnostic test for Alzheimer's disease, the company said today.

 

The university scientists, led by Mark Smith at the Department of Pathology, will use CombiMatrix's CustomArray microarray platform in their research.

 

CombiMatrix's platform uses electrochemically and independently addressable microelectrodes on semiconductor chips.

 

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.